Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosageChun‐Jen Liu, Pei‐Jer Chen, Deng‐Yn Lin et al.|Journal of Hepatology|2009Cited by 157